Literature DB >> 8971184

Bcl-xS enhances adenoviral vector-induced apoptosis in neuroblastoma cells.

M G Dole1, M F Clarke, P Holman, M Benedict, J Lu, R Jasty, P Eipers, C B Thompson, C Rode, C Bloch, V P Castle.   

Abstract

bcl-x is a member of the bcl-2 family of genes and by alternative splicing gives rise to two distinct mRNAs: bcl-xL and bcl-xS. We have previously investigated the expression of Bcl-x in neuroblastoma (NB) cell lines and have shown that Bcl-xL is expressed and functions to inhibit chemotherapy-induced apoptosis. However, none of the NB cell lines expressed Bcl-xS. The aim of the present study was to determine the effects of Bcl-xS expression on the viability of NB cells. A panel of NB cell lines (CHP-382, GOTO, SHEP-1, SHSY-5Y, and GI-CA-N) were infected with either a bcl-xS adenovirus (pAdRSV-bcl-xS) or a control virus (pAdRSV-lac-z). NB cells showed loss of viability with both viruses, although the bcl-xS virus was most toxic. Importantly, infection with the bcl-xS adenovirus resulted in rapid loss of cell viability, DNA fragmentation, and morphological features of apoptosis even in NB cells transfected to overexpress Bcl-2 and Bcl-xL. These findings suggest that deregulated expression of Bcl-xS using an adenovirus may provide a novel mechanism for initiating cell death in tumors that express Bcl-2 or Bcl-xL.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8971184

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  6 in total

1.  Regulation of Bcl-xL expression in lung vascular smooth muscle.

Authors:  Yuichiro J Suzuki; Hiroko Nagase; Chi Ming Wong; Shilpashree Vinod Kumar; Vivek Jain; Ah-Mee Park; Regina M Day
Journal:  Am J Respir Cell Mol Biol       Date:  2007-02-01       Impact factor: 6.914

2.  Killing of sarcoma cells by proapoptotic Bcl-X(S): role of the BH3 domain and regulation by Bcl-X(L).

Authors:  R S Mitra; M A Benedict; D Qian; K E Foreman; D Ekhterae; B J Nickoloff; G Nuñez
Journal:  Neoplasia       Date:  2001 Sep-Oct       Impact factor: 5.715

3.  The BH3 domain of Bcl-x(S) is required for inhibition of the antiapoptotic function of Bcl-x(L).

Authors:  B S Chang; A Kelekar; M H Harris; J E Harlan; S W Fesik; C B Thompson
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

4.  Emetine regulates the alternative splicing of Bcl-x through a protein phosphatase 1-dependent mechanism.

Authors:  Kritsanapol Boon-Unge; Qingming Yu; Tie Zou; An Zhou; Piyarat Govitrapong; Jianhua Zhou
Journal:  Chem Biol       Date:  2007-12

5.  Chimeric peptide nucleic acid compounds modulate splicing of the bcl-x gene in vitro and in vivo.

Authors:  Jeremy E Wilusz; Sean C Devanney; Massimo Caputi
Journal:  Nucleic Acids Res       Date:  2005-11-18       Impact factor: 16.971

Review 6.  Alternative splicing of BCL-X and implications for treating hematological malignancies.

Authors:  Wanling Chen; Jinggang Li
Journal:  Oncol Lett       Date:  2021-07-18       Impact factor: 2.967

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.